Try our new TumorMACS™ Media for ovarian, pancreatic, and renal tumor cells

Our TumorMACS™ Media are optimized for the generation of tumor cell cultures from primary and xenotransplanted pancreatic, ovarian, or renal tumor tissue. 

Benefit from preserved parental tumor heterogeneity, tumor-initiating capacity, and genetic stability of cultured cells. The stability and tumorigenicity of primary cell lines is maintained even after long-term in vitro propagation.

Find TumorMACS Media performance data below

Fill out the form below to ask for your discounted quote.
We will get in contact with you.

Please specify in which TumorMACS Media you are interested:

General Information

Detailed Information

Please give your details for further inquiries.

* Mandatory field

Questions / Comments

1 Terms and conditions

This offer is valid for customers in Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Iceland, Ireland, Italy, Japan, Luxemburg, Netherlands, New Zealand, Norway, Singapore, South Korea, Spain, Sweden, Switzerland, UK, and USA from February 01, 2020 to December 31, 2020. Only on the first purchase of each research group. The offer cannot be combined with any other promotion or discount. Deliveries are subject to Miltenyi Biotec’s General Business Terms and Conditions available at https://www.miltenyibiotec.com/legal-notes.html. Miltenyi Biotec reserves the right to end the promotion at any time.